150 related articles for article (PubMed ID: 33421566)
21. Differences in the Recurrence and Survival of Patients with Symptomatic and Asymptomatic Papillary Thyroid Carcinoma: An Observational Study of 11,265 Person-Years of Follow-Up.
Kim SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2016 Oct; 26(10):1472-1479. PubMed ID: 27457917
[TBL] [Abstract][Full Text] [Related]
22. The Identification of Intraoperative Risk Factors Can Reduce, but Not Exclude, the Need for Completion Thyroidectomy in Low-Risk Papillary Thyroid Cancer Patients.
Craig SJ; Bysice AM; Nakoneshny SC; Pasieka JL; Chandarana SP
Thyroid; 2020 Feb; 30(2):222-228. PubMed ID: 31813323
[No Abstract] [Full Text] [Related]
23. Extent of surgery affects survival for papillary thyroid cancer.
Bilimoria KY; Bentrem DJ; Ko CY; Stewart AK; Winchester DP; Talamonti MS; Sturgeon C
Ann Surg; 2007 Sep; 246(3):375-81; discussion 381-4. PubMed ID: 17717441
[TBL] [Abstract][Full Text] [Related]
24. Lobectomy Compared to Total Thyroidectomy for Low-Risk Papillary Thyroid Cancer: A Systematic Review.
Vargas-Pinto S; Romero Arenas MA
J Surg Res; 2019 Oct; 242():244-251. PubMed ID: 31103828
[TBL] [Abstract][Full Text] [Related]
25. Nomogram for Predicting Central Lymph Node Metastasis in Papillary Thyroid Cancer: A Retrospective Cohort Study of Two Clinical Centers.
Yang Z; Heng Y; Lin J; Lu C; Yu D; Tao L; Cai W
Cancer Res Treat; 2020 Oct; 52(4):1010-1018. PubMed ID: 32599980
[TBL] [Abstract][Full Text] [Related]
26. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2017 Feb; 27(2):207-214. PubMed ID: 27750022
[TBL] [Abstract][Full Text] [Related]
27. Does microscopically involved margin increase disease recurrence after curative surgery in papillary thyroid carcinoma?
Lang BH; Shek TW; Wan KY
J Surg Oncol; 2016 May; 113(6):635-9. PubMed ID: 26843438
[TBL] [Abstract][Full Text] [Related]
28. Recurrence following hemithyroidectomy in patients with low- and intermediate-risk papillary thyroid carcinoma.
Ahn D; Lee GJ; Sohn JH
Br J Surg; 2020 May; 107(6):687-694. PubMed ID: 32026467
[TBL] [Abstract][Full Text] [Related]
29. Management of Clinically Solitary Papillary Thyroid Carcinoma Patients According to Risk-Scoring Model for Contralateral Occult Carcinoma.
Feng JW; Ye J; Wu WX; Pan H; Qin AC; Jiang Y; Wu BQ
Front Endocrinol (Lausanne); 2020; 11():553577. PubMed ID: 33133013
[TBL] [Abstract][Full Text] [Related]
30. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients?
Ebina A; Sugitani I; Fujimoto Y; Yamada K
Surgery; 2014 Dec; 156(6):1579-88; discussion 1588-9. PubMed ID: 25262223
[TBL] [Abstract][Full Text] [Related]
31. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
32. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients.
Adam MA; Pura J; Gu L; Dinan MA; Tyler DS; Reed SD; Scheri R; Roman SA; Sosa JA
Ann Surg; 2014 Oct; 260(4):601-5; discussion 605-7. PubMed ID: 25203876
[TBL] [Abstract][Full Text] [Related]
33. Multifocality as independent prognostic factor in papillary thyroid cancer - A multivariate analysis.
Markovic I; Goran M; Besic N; Buta M; Djurisic I; Stojiljkovic D; Zegarac M; Pupic G; Inic Z; Dzodic R
J BUON; 2018; 23(4):1049-1054. PubMed ID: 30358210
[TBL] [Abstract][Full Text] [Related]
34. Thyroid Lobectomy for T1b-T2 Papillary Thyroid Cancer with High-Risk Features.
Suman P; Razdan SN; Wang CE; Tulchinsky M; Ahmed L; Prinz RA; Winchester DJ
J Am Coll Surg; 2020 Jan; 230(1):136-144. PubMed ID: 31672668
[TBL] [Abstract][Full Text] [Related]
35. Total thyroidectomy versus lobectomy for papillary thyroid cancer: A systematic review and meta-analysis.
Zhang C; Li Y; Li J; Chen X
Medicine (Baltimore); 2020 Feb; 99(6):e19073. PubMed ID: 32028431
[TBL] [Abstract][Full Text] [Related]
36. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
37. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
Pang R; Yang S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
[TBL] [Abstract][Full Text] [Related]
38. A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
He J; Tian Z; Yao X; Yao B; Liu Y; Yang J
Clin Exp Metastasis; 2020 Apr; 37(2):257-267. PubMed ID: 31792675
[TBL] [Abstract][Full Text] [Related]
39. Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):625-632. PubMed ID: 30841713
[TBL] [Abstract][Full Text] [Related]
40. Total vs hemithyroidectomy for intermediate risk papillary thyroid cancer: A 23 year retrospective study in a tertiary center.
Tsui KP; Kwan WY; Chow TL
Am J Otolaryngol; 2019; 40(3):431-434. PubMed ID: 30956005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
